Detection of an endogenous cannabimimetic molecule, 2-arachidonoylglycerol, and cannabinoid CB1 receptor mRNA in human vascular cells: is 2-arachidonoylglycerol a possible vasomodulator?

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  1998-02-24

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1006/BBRC.1998.8187PMID 9501013
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells.

  1997cited by this paper
• Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors.

  1997cited by this paper
• Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries

  1997cited by this paper
• Inhibition by 2-arachidonoylglycerol, a novel type of possible neuromodulator, of the depolarization-induced increase in intracellular free calcium in neuroblastoma x glioma hybrid NG108-15 cells.

  1997cited by this paper
• Cannabinoid CB1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat

  1997cited by this paper
• Production and physiological actions of anandamide in the vasculature of the rat kidney.

  1997cited by this paper
• Is the cannabinoid CB1 receptor a 2-arachidonoylglycerol receptor? Structural requirements for triggering a Ca2+ transient in NG108-15 cells.

  1997cited by this paper
• Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB 1 receptors on peripheral sympathetic nerves

  1996cited by this paper
• Mechanism of the hypotensive action of anandamide in anesthetized rats.

  1996cited by this paper
• 2-Arachidonoylglycerol, a putative endogenous cannabinoid receptor ligand, induces rapid, transient elevation of intracellular free Ca2+ in neuroblastoma x glioma hybrid NG108-15 cells.

  1996cited by this paper
• Isotope Dilution Mass Spectrometric Measurements Indicate That Arachidonylethanolamide, the Proposed Endogenous Ligand of the Cannabinoid Receptor, Accumulates in Rat Brain Tissue Post Mortem but Is Contained at Low Levels in or Is Absent from Fresh Tissue*

  1996cited by this paper
• Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Comparison with synthesis from free arachidonic acid and ethanolamine.

  1996cited by this paper
• Enzymatic synthesis of anandamide, an endogenous cannabinoid receptor ligand, through N-acylphosphatidylethanolamine pathway in testis: involvement of Ca(2+)-dependent transacylase and phosphodiesterase activities.

  1996cited by this paper
• Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat

  1996cited by this paper
• An endogenous cannabinoid as an endothelium-derived vasorelaxant.

  1996cited by this paper
• Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide.

  1995cited by this paper
• Occurrence and postmortem generation of anandamide and other long‐chain N‐acylethanolamines in mammalian brain

  1995cited by this paper
• 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.

  1995cited by this paper
• Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.

  1995cited by this paper
• Essential fatty acids and eicosanoids

  1993cited by this paper
• Isolation and structure of a brain constituent that binds to the cannabinoid receptor.

  1992cited by this paper
• Structure of a cannabinoid receptor and functional expression of the cloned cDNA

  1990cited by this paper
• Nucleotide sequence of a human cannabinoid receptor cDNA.

  1990cited by this paper
• Bradykinin Stimulates Phosphoinositide Hydrolysis and Mobilization of Arachidonic Acid in Dorsal Root Ganglion Neurons

  1989cited by this paper
• Determination and characterization of a cannabinoid receptor in rat brain.

  1988cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Early changes in inositol lipids and their metabolites induced by platelet-derived growth factor in quiescent Swiss mouse 3T3 cells.

  1985cited by this paper
• Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA.

  1984cited by this paper
• Characterization of 1,2-diacylglycerol hydrolysis in human platelets. Demonstration of an arachidonoyl-monoacylglycerol intermediate.

  1983cited by this paper
• Marihuana in Man: Three Years Later

  1971cited by this paper
• A rapid method of total lipid extraction and purification.

  1959cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Acute and subacute cardiovascular effects of synthetic cannabinoid JWH-018 in rat

  2025cites this paper
• Monoacylglycerol Lipase and Cyclooxygenase-2 Expression in Osteoarthritic Human Knees

  2023cites this paper
• Pharmacognosy and Effects of Cannabinoids in the Vascular System.

  2022cites this paper
• The Endocannabinoid System as a Therapeutic Target in Diabetic Peripheral Neuropathic Pain: A Review

  2021cites this paper
• Associations between cannabis use and retinal vessel diameter in young adults.

  2020cites this paper
• Impact of tetrahydrocannabinol on the endocannabinoid 2-arachidonoylglycerol metabolism: ABHD6 and ABHD12 as novel players in human placenta.

  2020cites this paper
• Cannabinoids and Cardiovascular System.

  2019cites this paper
• Bone marrow sinusoidal endothelium as a facilitator/regulator of cell egress from the bone marrow.

  2019cites this paper
• Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly

  2018cites this paper
• The endocannabinoid system in canine Steroid-Responsive Meningitis-Arteritis and Intraspinal Spirocercosis

  2018cites this paper
• Activation of CaMKKβ/AMPKα pathway by 2‐AG in human platelets

  2018cites this paper
• Endocannabinoid-mediated modulation of Gq protein-coupled receptor mediates vascular hyporeactivity to nor-adrenaline during polymicrobial sepsis

  2018cites this paper
• The endocannabinoid system in cardiovascular function: novel insights and clinical implications

  2018cites this paper
• Control of myogenic tone and agonist induced contraction of intramural coronary resistance arterioles by cannabinoid type 1 receptors and endocannabinoids.

  2017cites this paper
• ALLOSTERIC INTERACTIONS WITHIN CANNABINOID RECEPTOR 1 (CB1) AND DOPAMINE RECEPTOR 2 LONG (D2L) HETEROMERS

  2017cites this paper
• Characterization of endocannabinoids and related acylethanolamides in the synovial fluid of dogs with osteoarthritis: a pilot study

  2017influential citation
• ARCHIVOS DE LA SOCIEDAD ESPAÑOLA DE OFTALMOLOGÍA

  2016cites this paper
• Regulation of cAMP Intracellular Levels in Human Platelets Stimulated by 2‐Arachidonoylglycerol

  2016cites this paper
• Endocannabinoids in cerebrovascular regulation.

  2016cites this paper
• Endocannabinoids and the Cardiovascular System in Health and Disease.

  2015cites this paper
• Endocannabinoid-mediated modulation of Gq/11 protein-coupled receptor signaling-induced vasoconstriction and hypertension.

  2015cites this paper
• Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation

  2015cites this paper
• Cyclooxygenase metabolism mediates vasorelaxation to 2-arachidonoylglycerol (2-AG) in human mesenteric arteries

  2014cites this paper
• Acyltransferases and transacylases that determine the fatty acid composition of glycerolipids and the metabolism of bioactive lipid mediators in mammalian cells and model organisms.

  2014cites this paper
• 2-Arachidonoylglycerol modulates human endothelial cell/leukocyte interactions by controlling selectin expression through CB1 and CB2 receptors.

  2014cites this paper
• Vascular targets for cannabinoids: animal and human studies

  2014cites this paper
• [Role of endocannabinoid 2-arachidonoylglycerol in the physiology and pathophysiology of the cardiovascular system].

  2014cites this paper
• The Endocannabinoid/Endovanilloid N-Arachidonoyl Dopamine (NADA) and Synthetic Cannabinoid WIN55,212-2 Abate the Inflammatory Activation of Human Endothelial Cells*

  2014cites this paper
• Attenuates Its Vasoconstrictor Effect via Endocannabinoid Release, Which Angiotensin II Induces Vascular

  2014cites this paper
• Analysis of anandamide- and lysophosphatidylinositol-induced inhibition of the vasopressor responses produced by sympathetic stimulation or noradrenaline in pithed rats.

  2013cites this paper
• Arachidonate Remodeling and Inflammation

  2012cites this paper
• Progesterone-dependent regulation of endometrial cannabinoid receptor type 1 (CB1-R) expression is disrupted in women with endometriosis and in isolated stromal cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).

  2012cites this paper
• Angiotensin II Induces Vascular Endocannabinoid Release , Which Attenuates Its Vasoconstrictor Effect via CB 1 Cannabinoid Receptors *

  2012cites this paper
• Angiotensin II Induces Vascular Endocannabinoid Release, Which Attenuates Its Vasoconstrictor Effect via CB1 Cannabinoid Receptors*

  2012cites this paper
• Triphasic blood pressure responses to cannabinoids: do we understand the mechanism?

  2012cites this paper
• Activation of human platelets by 2-arachidonoylglycerol: role of PKC in NO/cGMP pathway modulation.

  2011cites this paper
• The differential effect of CB1 receptors on the discharge of afferent and efferent fibres supplying the rat jejunum

  2011cites this paper
• [Cannabinoid applications in glaucoma].

  2011cites this paper
• Activation by 2‐arachidonoylglycerol of platelet p38MAPK/cPLA2 pathway

  2011cites this paper
• Aplicaciones de los cannabinoides en glaucoma

  2011cites this paper
• Role of the Endocannabinoid System in Systems Toxicity

  2011cites this paper
• Cannabinoid applications in glaucoma

  2011cites this paper
• A Role for S1P and S1P1 in Immature-B Cell Egress from Mouse Bone Marrow

  2010cites this paper
• Rimonabant inhibits TNF-α-induced endothelial IL-6 secretion via CB1 receptor and cAMP-dependent protein kinase pathway

  2010cites this paper
• Reducing Acyl Migration during Purification of 2-Arachidonoylglycerol from Biological Samples before Gas Chromatography Mass Spectrometry Analysis

  2010cites this paper
• Cannabis-associated arteritis.

  2010cites this paper
• Physiological roles of 2‐arachidonoylglycerol, an endogenous cannabinoid receptor ligand

  2009cites this paper
• Endocannabinoids and the Heart

  2009cites this paper
• MINI-SYMPOSIUM ON FOOD VULNERABILITY IN SOCIETY: Sentinal Chemical Messengers: Endocannabinoid signaling transcends pain

  2009cites this paper
• The endocannabinoid 2‐arachidonoylglycerol activates human platelets through non‐CB1/CB2 receptors

  2008cites this paper
• Biosynthesis of Anandamide and 2-Arachidonoylglycerol

  2008cites this paper
• Identification of Novel Endogenous Cytochrome P450 Arachidonate Metabolites with High Affinity for Cannabinoid Receptors*

  2008cites this paper
• Znaczenie kannabinoidów w niewydolności serca* Function of cannabinoids in heart failure

  2008cites this paper
• [Function of cannabinoids in heart failure].

  2008cites this paper
• Integrin clustering enables anandamide-induced Ca2+ signaling in endothelial cells via GPR55 by protection against CB1-receptor-triggered repression

  2008cites this paper
• Prejunctional and peripheral effects of the cannabinoid CB1 receptor inverse agonist rimonabant (SR 141716)

  2008cites this paper
• Vasorelaxation caused by cannabinoids: mechanisms in different vascular beds.

  2008cites this paper
• Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis

  2008cites this paper
• Role of endocannabinoids in cardiovascular shock.

  2008cites this paper
• Depolarization-induced rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain synaptosomes.

  2007cites this paper
• Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity.

  2007cites this paper
• Pharmacological analysis of cannabinoid receptor activity in isolated nerve-smooth muscle and epithelial preparations

  2007cites this paper
• [2-Arachidonoylglycerol: an endogenous cannabinoid receptor ligand].

  2007cites this paper
• Cannabinoids and cardiovascular disease: the outlook for clinical treatments.

  2007cites this paper
• Effect of chronic CB1 cannabinoid receptor antagonism on livers of rats with biliary cirrhosis.

  2007cites this paper
• Critical enzymes involved in endocannabinoid metabolism.

  2007cites this paper
• PAPEL DEL SISTEMA ENDOCANNABINOIDE EN EL ALCOHOLISMO: ESTUDIO EN MODELOS ANIMALES

  2007cites this paper
• Characterization of the vasorelaxation to methanandamide in rat gastric arteries.

  2006cites this paper
• Cannabinoid receptors in atherosclerosis

  2006cites this paper
• New insights into endocannabinoid degradation and its therapeutic potential.

  2006cites this paper
• Cannabinoid agonists induce relaxation in the bovine ophthalmic artery: evidences for CB1 receptors, nitric oxide and potassium channels

  2006cites this paper
• Therapeutic potential of targeting the endocannabinoids: implications for the treatment of obesity, metabolic syndrome, drug abuse and smoking cessation.

  2006cites this paper
• The Endocannabinoid System

  2006cites this paper
• Cannabinoid modulation of electrically evoked pH and oxygen transients in the nucleus accumbens of awake rats

  2006cites this paper
• Cannabinoid CB1 receptor recognition of endocannabinoids via the lipid bilayer: molecular dynamics simulations of CB1 transmembrane helix 6 and anandamide in a phospholipid bilayer

  2006cites this paper
• Anandamide Inhibits Endothelin-1 Production by Human Cultured Endothelial Cells: A New Vascular Action of This Endocannabinoid

  2006cites this paper
• Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand.

  2006cites this paper
• EFFECTS OF CASTRATION ON CANNABINOID CB1 RECEPTOR EXPRESSION AND ON THE BIOLOGICAL ACTIONS OF CANNABINOID IN THE PAROTID GLAND

  2006cites this paper
• [Endogenous cannabinoid receptor ligands--anandamide and 2-arachidonoylglycerol].

  2006cites this paper
• Cannabinoids for therapeutic use in atherosclerosis

  2006cites this paper
• Cannabinoids for therapeutic use in atherosclerosis 1

  2006cites this paper
• 内在性カンナビノイド受容体リガンド—アナンダミドと2-アラキドノイルグリセロール

  2006cites this paper
• Involvement of cannabinoid CB(2) receptor-mediated response and efficacy of cannabinoid CB(2) receptor inverse agonist, JTE-907, in cutaneous inflammation in mice.

  2005cites this paper
• The endocannabinoid signalling system: biochemical aspects.

  2005cites this paper
• Endothelium-derived 2-arachidonylglycerol: an intermediate in vasodilatory eicosanoid release in bovine coronary arteries.

  2005cites this paper
• The biosynthesis, fate and pharmacological properties of endocannabinoids.

  2005cites this paper
• Human studies of cannabinoids and medicinal cannabis.

  2005cites this paper
• Review article: endocannabinoids and their receptors in the enteric nervous system

  2005cites this paper
• U-46619 but not serotonin increases endocannabinoid content in middle cerebral artery: evidence for functional relevance.

  2005cites this paper
• 2-Arachidonoylglycerol Increases in Ischemia–Reperfusion Injury of the Rat Liver

  2005cites this paper
• Endocannabinoids in Fertilization, Pregnancy, and Development

  2005cites this paper
• Endocannabinoids and the Cardiovascular System

  2005cites this paper
• The Relationship between Endocannabinoid Conformation and Endocannabinoid Interaction at the Cannabinoid Receptors

  2005cites this paper
• Occurrence, Biosynthesis, and Metabolism of Endocannabinoids

  2005cites this paper
• Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling

  2004cites this paper
• Endocannabinoids and their involvement in the neurovascular system.

  2004cites this paper
• 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells.

  2004cites this paper
• Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.

  2004cites this paper
• Immunohistochemical Localization of Cerebrovascular Cannabinoid CB1 Receptor Protein

  2004cites this paper
• 2-Arachidonoyl glycerol induces contraction of isolated rat aorta: role of cyclooxygenase-derived products.

  2004cites this paper